Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: A review

Timothy Masterson, Kevin R. Rice, Stephen D W Beck

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Testicular germ cell tumors represent a biologically unique disease process. These tumors are exquisitely sensitive to platinum-based chemotherapy, can be cured with surgical metastasectomy, and are known for the integration of biologic markers to stage and assign risk. Exploring further biologic markers that offer insight into the molecular mechanisms that contribute to disease biology is important. In this review, we attempt to summarize the utility of the current and some future biologic markers for disease monitoring and relapse.

Original languageEnglish
Pages (from-to)261-271
Number of pages11
JournalUrologic Oncology: Seminars and Original Investigations
Volume32
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Disease Progression
Biomarkers
Recurrence
Metastasectomy
Platinum
Drug Therapy
Testicular Germ Cell Tumor
Neoplasms

Keywords

  • Angiogenesis
  • Biomarkers
  • Epigenetics
  • Gene profiling
  • Germ cell tumor
  • Serum tumor markers
  • Testicular cancer

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Medicine(all)

Cite this

Current and future biologic markers for disease progression and relapse in testicular germ cell tumors : A review. / Masterson, Timothy; Rice, Kevin R.; Beck, Stephen D W.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 32, No. 3, 2014, p. 261-271.

Research output: Contribution to journalArticle

@article{df7a113376f0414f9d3850cb85e668ac,
title = "Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: A review",
abstract = "Testicular germ cell tumors represent a biologically unique disease process. These tumors are exquisitely sensitive to platinum-based chemotherapy, can be cured with surgical metastasectomy, and are known for the integration of biologic markers to stage and assign risk. Exploring further biologic markers that offer insight into the molecular mechanisms that contribute to disease biology is important. In this review, we attempt to summarize the utility of the current and some future biologic markers for disease monitoring and relapse.",
keywords = "Angiogenesis, Biomarkers, Epigenetics, Gene profiling, Germ cell tumor, Serum tumor markers, Testicular cancer",
author = "Timothy Masterson and Rice, {Kevin R.} and Beck, {Stephen D W}",
year = "2014",
doi = "10.1016/j.urolonc.2013.05.012",
language = "English",
volume = "32",
pages = "261--271",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Current and future biologic markers for disease progression and relapse in testicular germ cell tumors

T2 - A review

AU - Masterson, Timothy

AU - Rice, Kevin R.

AU - Beck, Stephen D W

PY - 2014

Y1 - 2014

N2 - Testicular germ cell tumors represent a biologically unique disease process. These tumors are exquisitely sensitive to platinum-based chemotherapy, can be cured with surgical metastasectomy, and are known for the integration of biologic markers to stage and assign risk. Exploring further biologic markers that offer insight into the molecular mechanisms that contribute to disease biology is important. In this review, we attempt to summarize the utility of the current and some future biologic markers for disease monitoring and relapse.

AB - Testicular germ cell tumors represent a biologically unique disease process. These tumors are exquisitely sensitive to platinum-based chemotherapy, can be cured with surgical metastasectomy, and are known for the integration of biologic markers to stage and assign risk. Exploring further biologic markers that offer insight into the molecular mechanisms that contribute to disease biology is important. In this review, we attempt to summarize the utility of the current and some future biologic markers for disease monitoring and relapse.

KW - Angiogenesis

KW - Biomarkers

KW - Epigenetics

KW - Gene profiling

KW - Germ cell tumor

KW - Serum tumor markers

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=84897039725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897039725&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2013.05.012

DO - 10.1016/j.urolonc.2013.05.012

M3 - Article

C2 - 24035725

AN - SCOPUS:84897039725

VL - 32

SP - 261

EP - 271

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 3

ER -